𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics

✍ Scribed by Richard S. Jope; Christopher J. Yuskaitis; Eléonore Beurel

Book ID
106483487
Publisher
Springer
Year
2006
Tongue
English
Weight
379 KB
Volume
32
Category
Article
ISSN
0364-3190

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glycogen synthase kinase 3 (GSK-3) inhib
Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
✍ Ana Martinez; Ana Castro; Isabel Dorronsoro; Mercedes Alonso 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Glycogen synthase kinase 3 (GSK-3) was initially described as a key enzyme involved in glycogen metabolism, but is now known to regulate a diverse array of cell functions. Two forms of the enzyme, GSK-3alpha and GSK-3beta, have been previously identified. Small molecules inhibitors of GSK-3 may, the

ChemInform Abstract: Glycogen Synthase K
ChemInform Abstract: Glycogen Synthase Kinase 3 (GSK-3) Inhibitors as New Promising Drugs for Diabetes, Neurodegeneration, Cancer, and Inflammation
✍ Ana Martinez; Ana Castro; Isabel Dorronsoro; Mercedes Alonso 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB 👁 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v